Whole Genome Sequencing i n advanced cancer cohort with clinical targeted sequencing
Not Applicable
Recruiting
- Conditions
- Neoplasms
- Registration Number
- KCT0007707
- Lead Sponsor
- Ajou University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
? Patients who have consented to the consent form for the subject and the consent form for human materials
? Patients over the age of 19 on the date of signing the consent form
? Patients who have the ability to make a written informed consent to voluntarily participate in this study
? Histologically confirmed advanced solid cancer patients (stage III or IV)
? Patients performing clinical targeted sequencing for diagnostic purposes during the treatment process
Exclusion Criteria
? Patients who do not understand or do not consent to written consent
? Patients who do not have sufficient residual DNA of 500 ng or more after the clinical panel sequencing test
? Patients who do not consent to genetic testing
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method clinical validity of WGS in the patients who perfomed panel NGS
- Secondary Outcome Measures
Name Time Method correlation between WGS and panel NGS